These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29197465)
21. CD44 and its role in inflammation and inflammatory diseases. Johnson P; Ruffell B Inflamm Allergy Drug Targets; 2009 Jul; 8(3):208-20. PubMed ID: 19601881 [TBL] [Abstract][Full Text] [Related]
23. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth. Bei R; Masuelli L; Palumbo C; Modesti M; Modesti A Cancer Lett; 2009 Aug; 281(1):8-23. PubMed ID: 19091462 [TBL] [Abstract][Full Text] [Related]
24. Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics. Melis JP; Strumane K; Ruuls SR; Beurskens FJ; Schuurman J; Parren PW Mol Immunol; 2015 Oct; 67(2 Pt A):117-30. PubMed ID: 25697848 [TBL] [Abstract][Full Text] [Related]
26. Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer. Bizzini B; Drouet B; Zagury D; Abitbol M; Burny A; Boissier MC Immunotherapy; 2010 May; 2(3):347-65. PubMed ID: 20635900 [TBL] [Abstract][Full Text] [Related]
32. [Current status of monoclonal antibodies in autoimmune diseases and problems associated with their clinical application]. Horiuchi A Nihon Rinsho; 1983; 41(4):830-3. PubMed ID: 6350652 [No Abstract] [Full Text] [Related]
34. T cell subtypes and its therapeutic potential in autoimmune diseases and cancer. Awasthi A; Kumar H Int Rev Immunol; 2019; 38(5):181-182. PubMed ID: 31608783 [No Abstract] [Full Text] [Related]
35. Antibodies in the breakdown lane. Blumberg RS; Lencer WI Nat Biotechnol; 2005 Oct; 23(10):1232-4. PubMed ID: 16211062 [No Abstract] [Full Text] [Related]
37. Autoimmunity: present-day concepts and future prospects. Hong R Curr Probl Pediatr; 1991 Jul; 21(6):253-8. PubMed ID: 1914513 [No Abstract] [Full Text] [Related]
38. Chemokine axis as a therapeutic target to enhance the recruitment of Tregs and treat organ-specific autoimmune and inflammatory diseases. Bayry J Immunotherapy; 2012 Jan; 4(1):9-12. PubMed ID: 22149994 [No Abstract] [Full Text] [Related]
39. -ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science? Ballow M J Allergy Clin Immunol; 2005 Oct; 116(4):738-43. PubMed ID: 16210044 [No Abstract] [Full Text] [Related]
40. Targeting TNF and its family members in autoimmune/inflammatory disease. Desplat-Jégo S; Burkly L; Putterman C Mediators Inflamm; 2014; 2014():628748. PubMed ID: 24803741 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]